Overview

Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients.

Status:
Not yet recruiting
Trial end date:
2031-05-30
Target enrollment:
Participant gender:
Summary
This is a randomized, open-label phase III clinical trial comparing antivascular therapy combined with standard chemotherapy and standard chemotherapy in adjuvant therapy for patients with triple-negative breast cancer, basal-like/Immune suppressed subtype.
Phase:
Phase 3
Details
Lead Sponsor:
Fudan University